The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A new option for post-CDK4/6is resistance era? Multicenter real-world study of anlotinib-based combination therapy in hormone receptor-positive metastatic breast cancer resistant to CDK4/6 inhibitors.
 
Binliang Liu
No Relationships to Disclose
 
Shao Bin
No Relationships to Disclose
 
Yi-Fei Chen
No Relationships to Disclose
 
Zhanhong Chen
No Relationships to Disclose
 
Xiaohong Wu
No Relationships to Disclose
 
Ying Zhang
No Relationships to Disclose
 
Fangyuan Dong
No Relationships to Disclose
 
Tao Sun
No Relationships to Disclose
 
Tao Wu
No Relationships to Disclose
 
Lu Gan
No Relationships to Disclose
 
Hong Zong
No Relationships to Disclose
 
Quchang Ouyang
No Relationships to Disclose